Where is SC-AMSA located?

SC-AMSA is headquartered in Marlborough, United States.

Where does SC-AMSA rank among its competitors?

SC-AMSA ranks 358th amongst 341 active competitors, of which 37 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Sebia, which secured an undisclosed amount in May, 2026.

Who are the top competitors of SC-AMSA?

SC-AMSA's top competitors include Enzo, Parse Biosciences and Sino Biological. Among them, Sebia secured the most recent funding round in May, 2026.

SC-AMSA - 2026 Company Profile & Competitors

SC-AMSA is an unfunded company based in Marlborough (United States), founded in 2025. It operates as a Manufacturer of high purity guide ribonucleic acid for research purposes. SC-AMSA has not raised any funding yet. The company has 341 active competitors, including 37 funded and 52 that have exited. Its top competitors include companies like Enzo, Parse Biosciences and Sino Biological.

Company Details

Manufacturer of high purity guide ribonucleic acid for research purposes. The business produces milligram scale samples to support screening and early development studies. Operations include the provision of analytical data reports to characterize sample quality and purity. Production capabilities extend to synthesizing long sequences and incorporating various chemical modifications. Transitions to larger scale manufacturing and clinical supply are coordinated through affiliated production facilities as project requirements advance.

Key Metrics

Founded Year

2025

Location

Marlborough, United States

Stage

Unfunded

Ranked

358^th among 413 competitors

Similar Companies

Parse Biosciences & 22 more

View SC-AMSA's full profile

SC-AMSA has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SC-AMSA include Enzo, Parse Biosciences and Sino Biological. Here is the list of Top 10 competitors of SC-AMSA, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	Battery Ventures	65/100
2nd	Parse Biosciences 2018, Seattle (United States), Series C	Developer of RNA-sequencing solution-based transcriptome kit to analyze health data	$100M	Marshall Wace, Janus Henderson Investors & 8 others	64/100
3rd	Sino Biological 2007, Beijing (China), Series A	Provider of reagents,and kits for clinical research	$29.4M	Qiming Venture Partners, CTS Capital & 1 others	63/100
4th	Devyser 2004, Stockholm (Sweden), Public	Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders	$15.5M	Swedbank Robur, Fjarde AP-fonden & 1 others	61/100
5th	Miltenyi Biotec 1989, Bergisch Gladbach (Germany), Funding Raised	Develops tools and products for research and clinical application	-	Europa, HHS	58/100
6th	Sebia 1967, Evry Courcouronnes (France), Acquired	Developer of electrophoresis-based in vitro diagnostics products	-	Warburg Pincus, HarbourVest Partners & 5 others	56/100
7th	BioIVT 1981, Westbury (United States), Acquired	Provider of in vitro diagnostic products and assay services	-	WILsquare Capital, Thompson Street Capital Partners ... & 4 others	56/100
8th	Teknova 1996, Hollister (United States), Public	Provider of molecular biology research reagents and kits	-	Cambrian Growth Partners, Telegraph Hill Partners ... & 1 others	56/100
9th	GenScript 2002, Piscataway (United States), Public	Provider of reagents and instruments for life sciences research	$15M	Kleiner Perkins, Vermögensclub & 1 others	55/100
10th	Firefly BioWorks 2009, Cambridge (United States), Acquired	Develops platform to allow multiplexed assays on standard laboratory instrumentation	$3.77M	PBM Capital, Breton Capital Ventures & 3 others	54/100
358th	SC-AMSA 2025, Marlborough (United States), Unfunded	Manufacturer of high purity guide ribonucleic acid for research purposes	-	-	16/100